专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06600269B2 Plasma display panel and method of manufacturing the same 失效
标题翻译：等离子显示面板及其制造方法
公开(公告)号：US06600269B2
公开(公告)日：2003-07-29
申请号：US09920334
申请日：2001-08-02
申请人： Toshihiro Yoshioka , Takashi Furutani
发明人： Toshihiro Yoshioka , Takashi Furutani
IPC分类号： G09G310
CPC分类号： H01J11/36 , H01J9/02 , H01J11/12 , H01J2211/363
摘要： In a plasma display panel, data electrodes are formed parallel to each other on a first substrate, and a selection voltage is to be applied to them. A dielectric layer covers a surface of the first substrate to include the data electrodes. Linear partitions are formed at a predetermined interval on the first substrate to be parallel to the data electrodes. A second substrate opposes the first substrate. A closed space between the first and second substrates is filled with a gas. Intersections of a pair of sustain discharge electrodes and data electrodes form matrix-like discharge cells. Stepped partitions are formed at a predetermined interval on the first substrate in a direction intersecting the linear partitions.
摘要翻译：在等离子体显示面板中，数据电极在第一基板上彼此平行地形成，并且对其施加选择电压。电介质层覆盖第一基板的表面以包括数据电极。在第一基板上以预定的间隔形成与数据电极平行的线性分隔。第二衬底与第一衬底相对。在第一和第二基板之间的封闭空间填充有气体。一对维持放电电极和数据电极的交点形成矩阵状放电单元。在与第一基板相交的方向上以预定间隔形成阶梯分隔。

2. 发明申请

US20050093776A1 Plasma display device and method for driving same 审中-公开
标题翻译：等离子体显示装置及其驱动方法
公开(公告)号：US20050093776A1
公开(公告)日：2005-05-05
申请号：US10951765
申请日：2004-09-29
申请人： Takashi Furutani , Toshihiro Yoshioka
发明人： Takashi Furutani , Toshihiro Yoshioka
IPC分类号： G09F9/313 , G09G3/20 , G09G3/288 , G09G3/291 , G09G3/293 , G09G3/294 , G09G3/298 , G09G3/36 , H01J11/12 , H01J11/14 , H01J11/22 , H01J11/24 , H01J11/26 , H01J11/28 , H01J11/34 , H01J11/36 , G09G3/28
CPC分类号： H01J11/24 , G09G3/288 , G09G3/298 , G09G3/2986 , G09G2310/0267 , G09G2320/0228 , G09G2320/0238 , H01J11/12 , H01J11/36 , H01J2211/245 , H01J2211/365 , H01J2211/444
摘要： A plasma display device and its driving method are provided which are capable of displaying an excellent image, without an increase in costs caused by an increased number of driving circuits, by shortening a scanning period while writing discharge is made to occur with reliability and by improving contrast. In a plasma display panel (PDP) in the plasma display device, a group of unit cells is formed at intersecting points between each of groups of row electrodes and a group of column electrodes. Each of unit cells is made up of a display cell and auxiliary cell and is surrounded by a horizontal rib and a longitudinal rib. A horizontal communicating aperture is formed in the longitudinal rib to partition among two or more auxiliary cells and a longitudinal communicating aperture is formed in the horizontal rib to partition between the display cell and auxiliary cell both being arranged in the column direction.
摘要翻译：提供了一种等离子体显示装置及其驱动方法，其能够显示优异的图像，而不增加驱动电路数量增加所引起的成本，通过缩短扫描周期，同时可以进行写入放电，并且通过改善对比。在等离子体显示装置中的等离子体显示面板（PDP）中，在各组行电极和一组列电极之间的交叉点处形成一组单位电池。每个单元电池由显示单元和辅助单元组成并且被水平肋和纵向肋围绕。在纵向肋中形成水平连通孔，以在两个或更多个辅助单元之间分隔，并且在水平肋中形成纵向连通孔，以在显示单元和辅助单元之间沿列方向布置。

3. 发明申请

US20050258727A1 Display device, plasma display device, and optical filter 失效
标题翻译：显示装置，等离子体显示装置和滤光器
公开(公告)号：US20050258727A1
公开(公告)日：2005-11-24
申请号：US11130405
申请日：2005-05-17
申请人： Tadahiko Kanoh , Takashi Furutani
发明人： Tadahiko Kanoh , Takashi Furutani
IPC分类号： G02B5/22 , G02B5/20 , G09F9/00 , H01J5/16 , H01J17/49 , H01J29/88 , H01J61/40
CPC分类号： H01J11/44 , G02B5/20
摘要： The present invention provides an optical filter for a display device capable to improve the bright-location contrast, and a display device in particular a plasma display device incorporating the optical filter. In a transmittance spectrum of the optical filter, a transmittance in a region having a wavelength range of 430 nm to 445 nm, a transmittance in a region having a wavelength range of 535 to 560 nm, and a transmittance in a region having a wavelength range of 605 to 630 nm are set to 80% or less of the maximum transmittance over the entire visible wavelength region.
摘要翻译：本发明提供一种能够提高亮度对比度的显示装置的光学滤波器，特别是包括该滤光器的等离子体显示装置的显示装置。在滤光器的透射光谱中，在波长范围为430nm至445nm的区域中的透射率，波长范围为535至560nm的区域中的透射率和具有波长范围的区域中的透射率在整个可见光波长范围内将605〜630nm的最大透射率设定为80％以下。

4. 发明申请

US20110282066A1 SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER 审中-公开
标题翻译：用于治疗前列腺癌的物质的筛选方法
公开(公告)号：US20110282066A1
公开(公告)日：2011-11-17
申请号：US13146434
申请日：2010-01-26
申请人： Takashi Furutani , Kentaro Enjo , Aya Kikuchi , Sadao Kuromitsu , Yukitaka Ideyama , Tomoyuki Suzuki , Ryoko Kurihara
发明人： Takashi Furutani , Kentaro Enjo , Aya Kikuchi , Sadao Kuromitsu , Yukitaka Ideyama , Tomoyuki Suzuki , Ryoko Kurihara
IPC分类号： C07D211/32 , C07D209/04 , G01N33/53 , C07D235/12 , C07D401/04 , G01N33/535 , C07D235/06
CPC分类号： G01N33/5017 , G01N33/57434 , G01N2333/904 , Y10T436/200833
摘要： [Object] A screening method for a compound which is useful as an agent for treating 17βHSD type 5-related diseases and/or an agent for treating 17βHSD type 5-related cancer such as prostate cancer is provided.[Means for Solution] The present invention has been completed by establishing a screening method for a compound which is useful for treating 17βHSD type 5-related diseases, by manifesting a tumor by transplanting tumor cells to, for example, an immunodeficient mouse, topically administering a steroid which is a biosynthetic substance for a hormone into the tumor, and measuring the level of a hormone produced in the tumor.[Selected Figure] None
摘要翻译： [目的]提供可用作治疗17型和HSD5型相关疾病的药剂和/或用于治疗诸如前列腺癌之类的HSD5型相关癌症的药物的化合物的筛选方法。 [解决方案]本发明是通过建立一种可用于治疗17bb HSD5型相关疾病的化合物的筛选方法，通过将肿瘤细胞移植至例如免疫缺陷小鼠，局部施用作为激素进入肿瘤的生物合成物质的类固醇，并测量肿瘤中产生的激素的水平。 [已选图]无

5. 发明授权

US07728120B2 EML4-ALK fusion gene 有权
标题翻译： EML4-ALK融合基因
公开(公告)号：US07728120B2
公开(公告)日：2010-06-01
申请号：US11845498
申请日：2007-08-27
申请人： Hiroyuki Mano , Sadao Kuromitsu , Nobuaki Shindo , Takatoshi Soga , Takashi Furutani
发明人： Hiroyuki Mano , Sadao Kuromitsu , Nobuaki Shindo , Takatoshi Soga , Takashi Furutani
IPC分类号： C07H21/04
CPC分类号： C12N15/1137 , A61K31/506 , C07K14/47 , C07K2319/00 , C12N9/1205 , C12N2310/14 , C12Q1/485 , C12Q1/6886
摘要： The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, a method for detecting the fusion protein or polynucleotide, a method for screening a therapeutic agent for cancer, and a method for treating cancer that is shown to be positive for the fusion gene. Further, the present invention relates kit, primer set, and probe useful in the detection of cancer that is shown to be positive for the fusion gene.
摘要翻译：本发明人发现存在于某些癌症患者中的融合基因是癌基因。本发明涉及作为新型融合蛋白的多肽，编码多肽的多核苷酸，包含多核苷酸的载体，包含载体的转化细胞，检测融合蛋白或多核苷酸的方法，用于筛选治疗剂的方法癌症和治疗癌症的方法，所述方法显示为融合基因呈阳性。此外，本发明涉及可用于检测癌症的试剂盒，引物组和探针，其对于融合基因显示为阳性。

6. 发明申请

US20100099658A1 DI(ARYLAMINO)ARYL COMPOUND 有权
标题翻译： DI（ARYLAMINO）ARYL化合物
公开(公告)号：US20100099658A1
公开(公告)日：2010-04-22
申请号：US12448759
申请日：2008-07-04
申请人： Yutaka Kondoh , Kazuhiko Iikubo , Sadao Kuromitsu , Nobuaki Shindo , Takatoshi Soga , Takashi Furutani , Itsuro Shimada , Takahiro Matsuya , Kazuo Kurosawa , Akio Kamikawa , Hiroyuki Mano
发明人： Yutaka Kondoh , Kazuhiko Iikubo , Sadao Kuromitsu , Nobuaki Shindo , Takatoshi Soga , Takashi Furutani , Itsuro Shimada , Takahiro Matsuya , Kazuo Kurosawa , Akio Kamikawa , Hiroyuki Mano
IPC分类号： A61K31/397 , C07D239/72 , A61K31/497 , A61K31/517 , C07D413/02 , A61K31/5377 , C07D403/02 , A61K31/53 , C07D279/12 , A61K31/541 , A61P35/00
CPC分类号： A61K31/551 , A61K31/517 , A61K31/53 , A61K31/5377 , A61K31/541 , C07D239/95 , C07D251/18 , C07D251/48 , C07D251/50 , C07D251/52 , C07D251/70 , C07D401/12 , C07D401/14 , C07D403/12 , C07D417/12 , C07D471/10 , C07D487/08 , C07D491/113 , C07D498/10
摘要： The present invention provides a compound which is useful as an inhibitor against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins.As a result of extensive and intensive studies on compounds having an inhibitory effect against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins, the inventors of the present invention have found that the di(arylamino)aryl compound of the present invention has inhibitory activity against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins. This finding led to the completion of the present invention. The compound of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, lung cancer, non-small cell lung cancer, small cell lung cancer, EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive cancer, EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive lung cancer, or EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive non-small cell lung cancer, etc.
摘要翻译：本发明提供了可用作抑制EML4-ALK融合蛋白和突变型EGFR蛋白的激酶活性的化合物。作为对具有对EML4-ALK融合蛋白和突变型EGFR蛋白的激酶活性具有抑制作用的化合物的广泛和深入研究的结果，本发明的发明人已经发现本发明的二（芳基氨基）芳基化合物具有对EML4-ALK融合蛋白和突变型EGFR蛋白激酶活性的抑制活性。这一发现导致了本发明的完成。本发明的化合物可以用作预防和/或治疗癌症，肺癌，非小细胞肺癌，小细胞肺癌，EML4-ALK融合多核苷酸阳性和/或突变型EGFR多核苷酸的药物组合物，阳性癌症，EML4-ALK融合多核苷酸阳性和/或突变型EGFR多核苷酸阳性肺癌或EML4-ALK融合多核苷酸阳性和/或突变型EGFR多核苷酸阳性非小细胞肺癌等。

7. 发明授权

US07666873B2 N-phenyl-(2R,5S)dimethylpiperazine derivative 有权
标题翻译： N-苯基 - （2R，5S）二甲基哌嗪衍生物
公开(公告)号：US07666873B2
公开(公告)日：2010-02-23
申请号：US11861327
申请日：2007-09-26
申请人： Nobuaki Taniguchi , Masakazu Imamura , Masahiko Hayakawa , Kenichi Kawaguchi , Takenori Kimura , Isao Kinoyama , Hiroyuki Kaizawa , Minoru Okada , Takashi Furutani
发明人： Nobuaki Taniguchi , Masakazu Imamura , Masahiko Hayakawa , Kenichi Kawaguchi , Takenori Kimura , Isao Kinoyama , Hiroyuki Kaizawa , Minoru Okada , Takashi Furutani
IPC分类号： A61K31/497 , C07D401/00
CPC分类号： C07D213/75 , C07D213/84 , C07D239/42 , C07D295/215
摘要： The present invention relates to a novel N-phenyl-(2R,5S)dimethylpiperazine derivatives useful as antiandrogenic agent which exhibits a sufficient prostate gland reducing effect as compared with conventional compounds and are excellent in oral activity. The compound of the present application is useful in preventing or treating prostate cancer, benign prostatic hyperplasia, and the like. The present invention also provides a novel intermediate useful in producing the compound of the present invention.
摘要翻译：本发明涉及用作抗雄激素剂的新型N-苯基 - （2R，5S）二甲基哌嗪衍生物，其与常规化合物相比表现出足够的前列腺减少效果，口服活性优异。本申请的化合物可用于预防或治疗前列腺癌，良性前列腺增生等。本发明还提供了可用于制备本发明化合物的新型中间体。

8. 发明授权

US4737864A Still picture recording system with noise detection and frame counting during shift from reproduction of picture in motion to reproduction of still picture including an intermediate slow motion mode 失效
标题翻译：在从运动中的图像的再现到包括中间慢动作模式的静止图像的再现的移位期间具有噪声检测和帧计数的静止图像记录系统
公开(公告)号：US4737864A
公开(公告)日：1988-04-12
申请号：US831290
申请日：1986-02-20
申请人： Masataka Sekiya , Hideo Nishijima , Kaneyuki Okamoto , Isao Fukushima , Fumiaki Fujii , Katsumi Sera , Takashi Furutani
发明人： Masataka Sekiya , Hideo Nishijima , Kaneyuki Okamoto , Isao Fukushima , Fumiaki Fujii , Katsumi Sera , Takashi Furutani
IPC分类号： H04N5/93 , G11B15/18 , H04N5/783 , H04N5/937
CPC分类号： H04N5/783 , G11B15/1875
摘要： A still picture reproducing system for a magnetic recording and reproducing apparatus is disclosed. The system sends one frame in order to shift a reproduction mode from ordinary reproduction to reproduction of a still picture by use of so-called "fine slow", sends one more frame if a noise is detected on a picture at this time, and stops if no noise is detected.
摘要翻译：公开了一种用于磁记录和再现装置的静止图像再现系统。系统发送一帧，以便通过使用所谓的“精细缓慢”将再现模式从普通再现移动到静止图像的再现，如果此时在图像上检测到噪声，则再发送一帧，并停止如果没有检测到噪声。

9. 发明申请

US20130197009A1 ANTAGONIST FOR MUTANT ANDROGEN RECEPTOR 审中-公开
标题翻译：拮抗剂对突变型受体的拮抗作用
公开(公告)号：US20130197009A1
公开(公告)日：2013-08-01
申请号：US13877358
申请日：2011-10-21
申请人： Yukitaka Ideyama , Sadao Kuromitsu , Takashi Furutani , Masayoshi Takeda , Satoshi Konagai , Tomohiro Yamada , Nobuaki Taniguchi , Yutaka Kondoh , Masaaki Hirano , Kazushi Watanabe , Takashi Sugane , Akio Kakefuda
发明人： Yukitaka Ideyama , Sadao Kuromitsu , Takashi Furutani , Masayoshi Takeda , Satoshi Konagai , Tomohiro Yamada , Nobuaki Taniguchi , Yutaka Kondoh , Masaaki Hirano , Kazushi Watanabe , Takashi Sugane , Akio Kakefuda
IPC分类号： C07D401/02 , C07D401/14 , C07D403/02
CPC分类号： C07D401/02 , A61K31/496 , A61K31/506 , C07D401/12 , C07D401/14 , C07D403/02 , C07D403/12
摘要： [Problem] An object of the present invention is to provide a novel anticancer drug which is useful for treating prostate cancer accompanying androgen receptor mutation[Means for Solution] The present inventors conducted thorough research on mutant androgen-related diseases for which the traditional anti-androgen drugs become ineffective. As a result, they found that the compound, which is an active ingredient of the pharmaceutical composition of the present invention, exhibits an inhibitory action against transcriptional activation in a human mutant androgen receptor (AR), and has an excellent antitumor action in a human prostate cancer-bearing mouse, thereby completing the present invention. Accordingly, the compound, which is an active ingredient of the pharmaceutical composition of the present invention, is useful for a series of androgen receptor-related diseases including prostate cancer.
摘要翻译：本发明的目的在于提供一种可用于治疗伴随雄激素受体突变的前列腺癌的新型抗癌药物。本发明人进行了关于雄激素相关疾病的全面研究，雄激素药物变得无效。结果发现，作为本发明的药物组合物的活性成分的化合物在人突变型雄激素受体（AR）中表现出对转录活化的抑制作用，并且在人体中具有优异的抗肿瘤作用前列腺癌的小鼠，从而完成本发明。因此，作为本发明的药物组合物的活性成分的化合物可用于一系列与前列腺癌有关的雄激素受体相关疾病。

10. 发明申请

US20120178611A1 GLASS PASTE FOR PLASMA DISPLAY PANEL AND PLASMA DISPLAY PANEL 审中-公开
标题翻译：用于等离子显示面板和等离子显示面板的玻璃浆
公开(公告)号：US20120178611A1
公开(公告)日：2012-07-12
申请号：US13395220
申请日：2011-07-05
申请人： Hiroyuki Ajiki , Yukako Doi , Yasuhiko Nakada , Takashi Furutani
发明人： Hiroyuki Ajiki , Yukako Doi , Yasuhiko Nakada , Takashi Furutani
IPC分类号： C03C14/00 , B32B5/16 , B32B3/26 , C03C3/00
CPC分类号： H01J11/12 , C03C8/14 , C03C17/007 , C03C2217/465 , H01J11/38 , Y10T428/2982
摘要： A glass paste for a plasma display panel includes at least dielectric glass fine particles and hollow fine particles. The dielectric glass fine particle has a spherical shape or a scaly shape. Average particle diameter d1 of the dielectric glass fine particles is at most 120 nm, and a largest particle diameter thereof is at most 400 nm. Average particle diameter d2 of the hollow fine particles is at most 120 nm, and a largest particle diameter thereof is at most 400 nm.
摘要翻译：用于等离子体显示面板的玻璃浆料至少包括电介质玻璃微粒和中空微粒。电介质玻璃微粒具有球形或鳞片状。电介质玻璃微粒的平均粒径d1为120nm以下，最大粒径为400nm以下。中空微粒的平均粒径d2为120nm以下，最大粒径为400nm以下。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式